LENZ Therapeutics Inc.

25.08
0.41 (1.66%)
At close: Jan 28, 2025, 2:01 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a 15.00M n/a n/a n/a
Cost of Revenue 2.41M 8.35M 734.00K 121.00K n/a
Gross Profit -2.41M 6.65M -734.00K -121.00K n/a
Operating Income -73.11M -105.64M -60.44M -13.50M -29.00K
Interest Income 10.95M n/a n/a n/a n/a
Pretax Income -124.65M -101.05M -70.76M -68.37M -109.00K
Net Income -124.65M -101.05M -70.76M -68.37M -109.00K
Selling & General & Admin 40.97M 32.85M 21.78M 4.26M 29.00K
Research & Development 29.73M 64.44M 37.93M 9.12M n/a
Other Expenses n/a 19.00K -869.00K n/a n/a
Operating Expenses 70.70M 97.29M 59.71M 13.38M 29.00K
Interest Expense n/a n/a n/a 40.00K 80.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 73.11M 105.64M 60.44M 13.50M 29.00K
Income Tax -124.65M 347.00K 497.44K n/a -171.86K
Shares Outstanding (Basic) 8.15M 7.84M 8.29M 8.30M 8.30M
Shares Outstanding (Diluted) 8.15M 7.84M 8.29M 8.30M 8.30M
EPS (Basic) -15.3 -12.89 -8.54 -8.24 -0.01
EPS (Diluted) -15.3 -12.89 -8.54 -8.24 -0.01
EBITDA -122.24M -97.29M -70.03M -68.21M -29.00K
Depreciation & Amortization 2.41M 8.35M 734.00K 121.00K 171.86K